NICE approves osteoporosis treatment that could benefit 14,000 people at high risk of fracture Abaloparatide will provide an alternative for women after menopause who have not responded to, or cannot tolerate, usual treatment options.…
Managing osteoporosis in older people How to understand bone health in the context of the older person, including risk assessment, prevention and the management of osteoporosis in patients likely to have multiple comorbidities.…
No evidence vitamin D supplements improve bone health, major analysis finds Vitamin D supplements for adults do not prevent fractures, falls or improve bone mineral density, according to authors of the biggest review of evidence to date.…
Alendronate may lower cardiovascular risk in hip fracture patients Study finds a treatment for osteoporosis may reduce the risk of cardiovascular events in people with hip fractures.…
Treatment options for menopausal symptoms Pharmacists and healthcare professionals can provide a patient-centred approach to advising women about the menopause, and provide robust information about the risks and benefits of menopause hormone treatment that will allow patients to make an informed choice about how to relieve their s…
Romosozumab reduces fracture risk in postmenopausal women with osteoporosis Researchers find that the drug can be an effective treatment for women who are susceptible to fracture.…
Alendronate might help protect against hip fractures Patients treated with prednisolone are likely to benefit from receiving the osteoporosis treatment alendronate, but further research is needed.…
Osteoporosis drugs may cause microcracks in bone Bisphosphonates are prescribed to prevent fractures in osteoporosis, but new research suggests that, paradoxically, they can also cause tiny cracks in bone…
Why some patients are reluctant to take osteoporosis drugs There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.…
Osteoporosis: moving beyond bisphosphonates Bisphosphonates are the mainstay of osteoporosis treatment but as more is elucidated about the underlying pathology of the condition, new drug targets are being investigated.…
